NYSE:ARMKHospitality
Assessing Aramark’s (ARMK) Valuation After Revenue Beat, Record Client Retention And New Healthcare Wins
Aramark (ARMK) is back in focus after reporting better-than-expected quarterly revenue, record client retention and fresh healthcare contract wins, while reaffirming guidance that indicates continued organic growth and operating income expansion.
See our latest analysis for Aramark.
Despite the latest revenue beat and record retention, Aramark’s 1-day share price return of a 7.18% decline to US$39.16 contrasts with its 7.05% year to date share price gain and solid 5-year total shareholder...